BMJ  2004;329 (13 November), doi:10.1136/bmj.329.7475.0-c

Policies on essential drugs help contain costs

Rich countries seeking to contain escalating drug expenditures should learn from the experience of the many developing countries that have adopted WHO's essential medicines policies, says Hogerzeil (p 1169). Although rich countries have adopted components of the policies WHO advocates, including evidence based clinical guidelines, they should also consider establishing lists of essential medicines based on sound scientific review and public health imperatives.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

The concept of essential medicines: lessons for rich countries
Hans V Hogerzeil
BMJ 2004 329: 1169-1172. [Extract] [Full Text] [PDF]

Access jobs at BMJ Careers
Whats new online at Student BMJ